...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZHCLF
1
Jan 03, 2024 11:19AM
1
Jan 03, 2024 05:13PM
2
Jan 03, 2024 06:48PM
1
Jan 03, 2024 09:36PM
1
Jan 03, 2024 10:53PM
2
Jan 03, 2024 10:56PM
2
Jan 04, 2024 07:35AM
1
Jan 30, 2024 02:24PM
4
Jan 30, 2024 04:37PM
1
Jan 31, 2024 08:28AM
3
Feb 01, 2024 08:20AM
3
Feb 01, 2024 10:24AM
6
Feb 01, 2024 10:55AM
5
Feb 02, 2024 07:27AM
4
Feb 06, 2024 11:23AM
3
Feb 08, 2024 06:43AM

Resent this am,,,simple fair question imo and not looking for info that is material and might fall under certain disclsure rules,,just a basic question is all!!!

 

 

info@zenithepigenetics.com'

Hello Investor Relations,

                Hope all is good with Zenith,,,,,,,Will there be some data released from the trials we are collaborating on with these Pharmas in 2024? I see we expect to complete 7 of the initial Pl and Pll trials in H1, with 4 more by year end.

Thanks for any info offered.

6
Feb 08, 2024 10:46AM
8
Feb 11, 2024 07:57AM
Share
New Message
Please login to post a reply